Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 98%
filed 2026-09-14
Item 1.01
Hain Celestial entered into a definitive Share Purchase Agreement on September 12, 2026, to sell its International business (including Ella's Kitchen, Joya, Natumi, Hartley's, Cully & Sully, Yorkshire Provender, and New Covent Garden brands) to AURELIUS-affiliated entities for approximately £238.5 million (≈$323.2 million gross, ≈$305–310 million net), representing approximately half of the company's revenue.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-14
Item 1.01
AirJoule Technologies acquired 100% of BitSink LLC on September 10, 2026, for $18 million in cash and 1,859,504 shares of Class A common stock (valued at approximately $9 million), plus up to $40 million in earnout consideration tied to revenue milestones. The acquisition expands AirJoyle's addressable market from $20 billion to $70 billion and adds a profitable operating business with $11 million in cumulative 2024–2025 revenue, $15 million in near-term purchase orders, U.S. manufacturing capabilities, and 220+ MW of deployed equipment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-14
Item 1.01
Perdoceo Education Corporation entered into a definitive Membership Interest Purchase Agreement on September 14, 2026, to acquire 100% of South University Savannah, LLC for approximately $150 million in initial cash consideration plus $18 million in deferred payments and up to $56 million in earn-out payments. The acquisition of this substantial educational institution with $291 million in annual revenues and 10,500 students is expected to be immediately accretive to adjusted operating income beginning in 2027 and materially expands Perdoceo's graduate health sciences offerings.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-14
Item 8.01
The filing discloses the expiration of the "go-shop" period under a definitive merger agreement dated August 10, 2026, whereby Bernhard Capital Partners will acquire Bowman Consulting Group in an all-cash transaction for $43.00 per share (approximately $1.0 billion enterprise value). This represents a material M&A transaction that is expected to close in Q4 2026, subject to shareholder approval and regulatory conditions. The disclosure confirms the transaction remains on track following the unsuccessful solicitation period.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-14
Item 7.01
Enova announced the withdrawal of its applications with the Office of the Comptroller of the Currency and the Board of Governors of the Federal Reserve System related to the proposed acquisition of Grasshopper Bancorp, Inc. This represents termination of a material acquisition transaction that was previously disclosed and under regulatory review. The CEO's statement emphasizes this was a strategic decision after "thorough evaluation," making it a significant M&A event affecting shareholder value and corporate strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-14
Item 2.01
Quince Therapeutics completed the sale of its Italian subsidiary (Quince Therapeutics SpA), intellectual property related to its AIDE/eDSP technology platform, and manufacturing systems to Ayma Therapeutics for $450,000 cash on September 8, 2026. This material divestiture eliminates a significant business line and is expected to reduce annual R&D expenses by $26.6M.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-14
Item 7.01
This Item 7.01 disclosure announces an enhanced Virginia benefits package in connection with the "previously disclosed combination with NextEra Energy, Inc." The press release details material commitments tied to the proposed merger, including $10/month residential bill credits for four years, $100 million in EnergyShare funding, 1,000 new jobs, and a shareholder-funded co-headquarters tower in Richmond. While technically a Regulation FD disclosure of a press release, the substance is an update to a material acquisition transaction that would affect investor assessment of the deal's terms and regulatory prospects.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-14
Item 1.01
Odyssey Marine Exploration disclosed a proposed merger with AOM, a material acquisition transaction requiring stockholder approval. The merger agreement is incorporated by reference in Item 2.03 and represents a significant change-of-control event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-14
Ascendis announced on September 14, 2026, that it will regain exclusive rights to develop, manufacture, and commercialize TransCon technology-based products in metabolic and cardiovascular diseases following termination of its collaboration agreement with Novo Nordisk A/S. This represents a material change in control and reversion of significant intellectual property rights, including rights to once-monthly TransCon Semaglutide, with no continuing financial obligations between parties—a substantive alteration of the registrant's asset portfolio and commercial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 89%
filed 2026-09-14
Item 1.01
Onconetix entered into a Grid Promissory Note with Realbotix LLC providing up to $5.0 million in bridge financing to support the pending acquisition of Realbotix announced in February 2026. The bridge facility is automatically cancelled and discharged upon closing of the Share Exchange Agreement, reducing cash required at closing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-14
Item 2.01
Ondas Inc. completed the acquisition of GATE Technologies Ltd. and Bron Technologies sp. z.o.o. on September 14, 2026, for $105 million in cash, 10,689,655 shares of common stock (valued at $100 million), plus $25 million in working capital adjustment and up to $185 million in contingent earn-out payments through 2028. The acquisition expands Ondas' precision-strike platform with mission-critical electronic safe-and-arm and fuzing technologies, with expected Adjusted EBITDA contributions of $130+ million through 2028.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-14
The filing discloses Amendment No. 1 to a Business Combination Agreement dated September 14, 2026, among XCF Global, DevvStream, and Southern Energy. The Amendment materially modifies merger consideration (adjusting pro forma ownership percentages), deletes or modifies multiple closing conditions (including minimum capitalization, revenue run-rate, and HSR Act requirements), and establishes new funding commitments totaling up to $54.373 million. This is a material amendment to a proposed business combination that directly affects deal structure and closing conditions, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting ma_activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-09-14
Item 1.01
Elmet Group entered into a definitive investment agreement with the U.S. Department of War providing for a $450 million committed equity investment, including an initial $200 million closing and up to $250 million in additional tranches. The Department of War receives 19.9% voting power through preferred equity and warrants, board representation rights, and liquidation preferences, constituting a material capital transaction and change of control event with significant operational implications including facility expansions and new business divisions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-14
Item 1.01
The filing discloses entry into an Amended and Restated Definitive Merger Agreement on September 8, 2026, between DMAA and Power Analytics Global Corp (PAGC), with a fixed Closing Valuation of US$2,850,000,000. This is a material acquisition/merger transaction that restructures the blank-check company into a publicly traded holding company, directly triggering Item 1.01 disclosure requirements and materially affecting investor assessment of the registrant's future.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-14
EX-99.1
This news release discloses Aurora Cannabis's response to Curaleaf Holdings' hostile bid for acquisition. The release discusses the adequacy of the hostile offer, the Board's unanimous recommendation to reject it, and regulatory deficiencies in the bid process. While framed as a rebuttal, the core disclosure is the ongoing material acquisition activity—specifically a hostile takeover attempt by Curaleaf that Aurora's Board has rejected. This constitutes a material change of control event under Item 1.01/2.01 (M&A activity), as it directly addresses whether shareholders should accept or reject a proposed acquisition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-14
Item 2.01
Veracyte completed the acquisition of Convergent Genomics on September 14, 2026, for $150 million in upfront cash consideration plus up to $30 million in milestone-based payments. The transaction expands Veracyte's urology diagnostics portfolio with the UroAmp urinary tumor DNA testing platform, representing a material strategic expansion into bladder cancer diagnostics.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-14
Item 1.01
Addus HomeCare entered into a definitive Equity and Asset Purchase Agreement on September 12, 2026, to acquire AccentCare's personal care division outside New York for $275 million in cash, expected to add approximately $280 million in annualized revenue (roughly 19% increase to Addus' revenue base) and be accretive to financial results.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-14
The filing discloses termination of a material merger agreement between Embrace Change Acquisition Corp. and Tianji Tire Global (Cayman) Limited, originally entered into on January 26, 2025 and amended October 16, 2025. The termination notice was received on September 10, 2026, triggered by the Outside Date (August 12, 2026) passing without consummation. This is a material M&A event under Item 1.01 (Termination of a Material Definitive Agreement) that would materially affect investor assessment of the SPAC's prospects.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-14
EX-99.1
Almonty has entered into a binding agreement with the Government of Rwanda establishing a joint venture (Almonty Rwanda) in which Almonty holds 75% and the GOR holds 25% equity interest. The GOR contributes the Shyorongi tungsten exploration concession and a mineral processing license in exchange for its equity stake. This constitutes a material acquisition/formation of a joint venture with a strategic government partner, involving significant operational and exploration assets in Rwanda's tungsten sector, aligned with U.S. supply-chain security objectives.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-14
The filing discloses entry into a definitive Equity Purchase Agreement on September 13, 2026, whereby Nomadar Corp. (through its subsidiary Fox Soccer Holding Company LLC) will acquire a majority interest (51%) in Fox Soccer Academy, a multi-jurisdictional youth soccer organization operating in the U.S., U.K., and Austria. The transaction involves a complex consideration structure including equity interests (4.4M Class B Units representing 49% of the holding company), cash payments totaling $2.6M deferred over two years, and a contingent earnout of up to $1.5M. Item 1.01 explicitly covers "Entry into a Material Definitive Agreement," and the press release emphasizes this as a strategic expansion of Nomadar's international sports development platform.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-09-14
The filing discloses entry into a material definitive agreement—a Settlement Agreement and Amendment to License Agreement with Nerviano Medical Sciences—that resolves litigation and materially restructures Cardiff's exclusive worldwide license to develop and commercialize onvansertib, its lead PLK1 inhibitor. The Amendment includes revised royalty structures, development milestones, assignment provisions tied to Phase III outcomes, and governance rights (board observer, Scientific Advisory Board seat), fundamentally altering the parties' ongoing relationship and Cardiff's rights to its lead asset. While styled as a settlement and license amendment rather than a traditional M&A transaction, the material restructuring of Cardiff's exclusive rights and obligations to its lead product candidate constitutes a material change in the company's strategic position and financial obligations.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-14
JBDI Holdings entered into a stock purchase agreement on September 14, 2026 to acquire Club Versante Group Limited (a Canada-based restaurant group operating 3 establishments) for $20,000,000 in convertible promissory notes. This is a material acquisition transaction requiring Nasdaq approval and closing within approximately one month, directly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting M&A activity material to a reasonable investor.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-14
The filing discloses a reverse stock split (1-for-12.62) being implemented in connection with Impact Biomedical's proposed merger with Zoar Limited. The merger is the material transaction; the reverse split is a preparatory capital structure action to support the merger and regain NYSE American listing compliance. The filing explicitly states the reverse split is "being effected in connection with the Company's proposed merger" and references the merger agreement dated June 23, 2025, making this a material acquisition/business combination event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-14
EX-99.1
This news release announces a binding letter agreement dated September 11, 2026 among Blue Moon, The Elmet Group, and EQ Resources for a series of strategic transactions involving a US$150–175 million investment into Blue Moon's Springer Tungsten Complex. The transactions include formation of a joint venture entity to own and operate the APT plant, an equity investment by TEG into Blue Moon, a tungsten prepayment facility, and supply agreements. These constitute material acquisition and change-of-control activity under Item 1.01/2.01 of the 8-K taxonomy, as they involve significant capital deployment, equity dilution, operational restructuring (JV formation), and board representation rights that materially alter Blue Moon's capital structure and control relationships.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-14
YPF's subsidiary Vaca Muerta Inversiones S.A. completed the assignment of a 20% interest in joint venture contracts for the "La Escalonada" and "Rincón La Ceniza" Areas to Pluspetrol S.A., reducing VMI's stake from 45% to 25%. This is a material disposition of a significant interest in oil and gas assets, explicitly labeled a "Material Event" by the registrant in its letter to Argentine securities regulators, and represents a completion of a transaction previously announced on January 22 and April 30, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-14
Item 1.01
Thryv entered into a definitive Asset Purchase Agreement on September 12, 2026, to sell its print directories business (Yellow and White Pages in the US, Australia, and New Zealand) to Coldwater YP, LLC for $142 million in cash. This is a material disposition of a business segment, with proceeds earmarked to reduce debt and strengthen the balance sheet. The transaction is expected to close in Q4 2026 and materially improve the Company's financial profile, making it a core M&A activity disclosure under Item 1.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-09-14
EX-99.1
The Company reports execution of an "Equity Support Agreement" with its parent company Empresas Copec S.A., following shareholder approval on September 10, 2026. This equity contribution commitment represents a material capital transaction between the Company and its parent, affecting the Company's financial structure and control relationships. The filing explicitly characterizes this as a "Material Fact" under Chilean securities law and notes expected positive economic effects, signaling materiality to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-14
Item 7.01
Crane Company announced entry into a definitive agreement to acquire the U.S. pump business from Trillium Flow Technologies for approximately $240 million. This is a material acquisition disclosed via press release on Item 7.01 (Regulation FD Disclosure), representing a significant strategic transaction that expands the company's Process Flow Technologies segment and adds recognized brands (Floway, Wemco, Roto-Jet, WSP) with approximately $115 million in expected full-year revenue.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-14
EX-99.1
The press release announces the completion of three acquisitions by Vox Royalty's subsidiary: the White Dam Gold Royalty, the Kalman Copper Royalty, and the Sylvania Royalty in Australia, with aggregate cash consideration of A$8.4 million (~$6 million). The filing explicitly states these were "previously announced" acquisitions that have now been "completed," with all conditions precedent satisfied. This is a material acquisition event disclosing the consummation of multiple royalty purchases that expand the company's portfolio.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-14
Item 8.01
Curaleaf disclosed a material development in its pending acquisition of Aurora: the filing of an application with the Alberta Securities Commission to halt Aurora's at-the-market share issuance program during the offer period. This is a significant tactical action within an active M&A transaction that directly impacts the offer's economics (increasing cost by >US$11 million) and shareholder consideration. While the core M&A activity (the offer itself) was previously disclosed, this regulatory intervention represents a material event in the course of that transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 55%
filed 2026-09-14
Item 1.01
Future Vision II Acquisition Corp. entered into a material definitive agreement, with the substantive terms cross-referenced to Item 2.03 (debt issuance). The agreement relates to the company's ongoing business combination with MicroTouch Technology Inc., though the specific nature and full terms are not fully disclosed in the Item 1.01 section alone.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-11
Item 1.01
Net Power entered into three integrated Transaction Agreements with Baker Hughes affiliates on September 8, 2026, that materially restructure the parties' commercial relationship. The agreements indefinitely suspend the Amended and Restated Joint Development Agreement and Commercial Agreement, terminate Baker Hughes' access and exclusivity rights at the La Porte Demonstration Facility, and establish revised industrial-scale licensing arrangements. This represents a material modification of existing commercial arrangements that would affect a reasonable investor's assessment of the company's development and commercialization strategy, particularly the suspension of utility-scale oxy-combustion programs and the shift to industrial-scale licensing with uncertain royalty terms.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-11
Item 8.01
Centrus disclosed advanced discussions regarding the potential acquisition of an existing domestic manufacturing supplier with an anticipated purchase price of $115–$125 million and target revenue of approximately $160 million. Although no definitive agreement has been executed, the company is in material pre-acquisition negotiations that would enhance vertical integration and supply chain capabilities.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-11
Item 1.01
NewHold Investment Corp. III entered into a Forward Share Purchase Agreement dated September 11, 2026, with NewCleo and an unaffiliated stockholder, providing for a prepaid share forward transaction of up to 7,000,000 shares (approximately $74.55 million) to increase cash available to the combined company following the proposed business combination. This financing arrangement is integral to the previously disclosed Business Combination Agreement and is designed to support the transaction's completion and the combined entity's post-closing capitalization.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-09-11
Item 2.01
AtaiBeckley Inc. consummated a merger on the Closing Date, whereby the Company became a wholly owned subsidiary of the Merger Sub parent, with common stock converted into merger consideration and equity awards treated according to specified terms. All existing directors and officers resigned and were replaced by directors and officers from Merger Sub, constituting a change of control transaction.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-11
The 6-K discloses entry into a material definitive agreement on September 3, 2026, whereby the Company's subsidiary BVI 3e Holdings agreed to subscribe for 1,600,000 ordinary shares of hashbeaver tech Limited for US$1,600,000, resulting in a 9.7% ownership stake post-transaction. This constitutes a material investment/acquisition activity requiring disclosure under Item 1.01 (Entry into a Material Definitive Agreement).
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-11
Item 8.01
Alcoa is disclosing South32's notice of meeting and explanatory memorandum for a shareholder vote on the "proposed sale of South32's interests in certain bauxite, alumina and aluminum operations to Alcoa Corporation" pursuant to an Umbrella Implementation Deed dated June 30, 2026. This is a material acquisition by Alcoa of South32's aluminum value chain assets (other than Mozal), which constitutes a significant M&A transaction requiring shareholder approval and disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-11
Item 8.01
This Item 8.01 disclosure concerns the merger of Aon's subsidiary (Merger Sub) with USI Advantage, with USI Advantage surviving as a direct, wholly-owned subsidiary of Aon North America. The filing provides audited and unaudited financial statements of USI and pro forma combined financial statements reflecting the merger. This is a material acquisition activity under Item 1.01/2.01 framework, disclosed here with supporting financial exhibits required for SEC compliance in connection with the merger transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-11
Item 8.01
The filing discloses shareholder approval of a merger between BCPL Merger Sub, Inc. (a subsidiary of BC Partners Lending Corporation) and Alternative Credit Income Fund, with ACIF continuing as a wholly owned subsidiary of BCPL. This is a material acquisition/change of control event where shareholders voted overwhelmingly (84.6%) in favor. The transaction represents a significant corporate event affecting the registrant's structure and operations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-09-11
Item 2.01
Korsana Biosciences completed a merger with Cyclerion Therapeutics on September 8, 2026, with Korsana as the surviving entity. The combined company began trading on Nasdaq under ticker 'KRSA' on September 9, 2026, with approximately 55.1 million shares outstanding post-transaction, representing a material change of control and fundamental restructuring of the registrant.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-11
Aperture AC (a SPAC) and Atlantic HPC Group Inc. have entered into a definitive Business Combination Agreement dated September 10, 2026, whereby Aperture will acquire Atlantic for $150 million in equity consideration (15 million shares at $10/share), with up to 6 million additional earnout shares contingent on operational and stock price milestones. The transaction involves a merger structure with Atlantic becoming a wholly owned subsidiary of Aperture, and the combined company expected to trade on Nasdaq under ticker "AHPC." This is a material acquisition/change of control transaction requiring shareholder approval and SEC registration statement filing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-11
ChampionsGate Acquisition Corp announced entry into a definitive "Agreement and Plan of Merger and Business Combination Agreement" with Futuremain Co., Ltd., a Korean engineering and IT company. The transaction will result in Futuremain becoming an indirect wholly owned subsidiary of a newly formed Pubco, with Pubco shares valued at $10.00 per share and an estimated enterprise value of $80 million for Futuremain. This is a material acquisition/merger transaction disclosed under Item 7.01 (Regulation FD Disclosure) with a press release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-09-11
The filing discloses termination of a share purchase agreement for acquisition of Chinasky Car Trading FZE, a material M&A transaction originally valued at US$1,000,000 in consideration shares. The termination on September 10, 2026, represents a material change in the status of a previously announced acquisition, falling squarely within Item 1.02 (Termination of Material Agreements) or Item 2.01 (Completion of Acquisition or Disposition) framework for 8-K/6-K disclosure of M&A activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-11
Item 2.01
AIB Data Centers completed the acquisition of approximately 29.385 acres of Texas real property and related assets for approximately $17.2 million in aggregate consideration on September 11, 2026. The transaction comprised two linked components: a Purchase and Sale Agreement for Property A ($8.25M) and a Membership Interest Purchase Agreement for Property B ($8.975M), with contingent payment terms including a $6.0M deferred installment and $7.75M in standby letters of credit.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-11
Item 1.01 discloses entry into a Stock Purchase Agreement on September 11, 2026, whereby HWH International Inc. agreed to purchase all issued and outstanding shares of Hearty Nova Limited from Smart Dynamics Technology Limited for $1.00. Hearty Nova owns 51% of a joint venture company (China Gas Africa Clean Energy Investment Holdings Limited) that will develop and operate a natural gas processing plant in Nigeria, with the Company planning to invest $1,173,000 in the JV Company. This constitutes a material acquisition activity under Item 1.01, though the primary event is the entry into the definitive agreement rather than completion of the transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-11
The filing discloses a Sixth Amendment to the Master Credit Agreement (Item 1.01) that approves a sale of SMI (Southwestern Montana Insurance Center, LLC), a wholly owned subsidiary, with proceeds of approximately $2.4 million, of which $1.2 million is applied to debt repayment. The amendment permits the Company to retain the balance of proceeds and releases SMI as a borrower. This constitutes a material disposition of a subsidiary asset that materially affects the Company's capital structure and debt obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-11
The filing discloses a go-private strategic review process with a binding acquisition proposal from an existing shareholder offering $77.58 per share in cash to acquire all outstanding common stock. The Company has established a 60-day "go-shop" period ending October 5, 2026, to evaluate this proposal and competing bids. This represents a material change-of-control transaction under active consideration, even though no definitive agreement has been reached. The disclosure of the specific offer price, the go-shop process, and the timeline for decision-making are hallmarks of M&A activity material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-11
Item 2.01
Volato completed a merger with Aligned (Alignment Engine Inc.) in which Aligned's capital stock was converted into 79,078 shares of Series A Preferred Stock and 316,312 shares of Series A-1 Preferred Stock of Volato, representing 95% of Volato Common Stock on a fully diluted basis. The transaction involved issuance of merger consideration shares, options, warrants, and convertible preferred stock with specified conversion rights and liquidation preferences.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-11
Item 1.01
Silver Bow Mining completed the initial closing of a material asset purchase agreement to acquire specified assets of Montana Tunnels Mining, Inc. from bankruptcy court on September 4, 2026, involving approximately $28.58 million in cash payments and secured financing arrangements. This constitutes a material acquisition under Item 1.01 that would significantly affect a reasonable investor's assessment of the registrant's financial position and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-11
Item 8.01
Skye Bioscience entered into a Transaction Agreement dated August 14, 2026 to acquire Redx Pharma Limited. The company plans to file a proxy statement and seek stockholder approval for the proposed acquisition, which remains subject to customary closing conditions and regulatory approvals.
View raw filing on EDGAR →